Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Trend and Projection of Mortality Rate Due to Non-Communicable Diseases in Iran: A Modeling Study Publisher Pubmed



Shadmani FK1 ; Farzadfar F2 ; Larijani B3 ; Mirzaei M4 ; Haghdoost AA5
Authors
Show Affiliations
Authors Affiliations
  1. 1. Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Endocrinology and Metabolism Clinical Sciences Institute of Tehran University of medical sciences, Tehran, Iran
  4. 4. Department of biostatistics and epidemiology, School of Public Health, Kerman University of Medical Sciences, Kerman, Iran
  5. 5. Regional Knowledge Hub, WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Source: PLoS ONE Published:2019


Abstract

Background Following the epidemiologic and demographic transition, non-communicable disease mortality is the leading cause of death in Iran. Projecting mortality trend can provide valuable tools for policy makers and planners. In this article, we have estimated the trend of non-communicable disease mortality during 2001–2015 and have projected it until 2030 at national and subnational levels in Iran. Methods The data employed was gathered from the Iranian death registration system and using the Spatio-temporal model, the trends of 4 major categories of non-communicable diseases (cancers, cardiovascular diseases, asthma and COPD, and diabetes) by 2030 were projected at the national and subnational levels. Results The results indicated that age standardized mortality rate for cancers, CVDs, and Asthma and COPD will continue to decrease in both sexes (cancers: from 81.8 in 2015 to 45.2 in 2030, CVDs: 307.3 to 173.0, and Asthma and COPD: from 52.1 to 46.6); however, in terms of diabetes, there is a steady trend in both sexes at national level (from 16.6 to 16.5). Age standardized mortality rates for cancers and CVDs, in males and females, were high in all provinces in 2001. The variation between the provinces is clearer in 2015, and it is expected to significantly decrease in all provinces by 2030. Conclusion Generally, the age standardized mortality rate from NCDs will decrease by 2030. Of course, given the experience of the past two decades in Iran, believing that the mortality rate will decrease may not be an easy notion to understand. However hard to believe, this decrease may be the result of better management of risk factors and early detection of patients due to more comprehensive care in all segments of society, as well as improved literacy and awareness across the country. © 2019 Khosravi Shadmani et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Other Related Docs
21. The Trend of Fall-Related Mortality at National and Provincial Levels in Iran From 1990 to 2015, International Journal of Injury Control and Safety Promotion (2020)
28. National and Subnational Mortality of Urological Cancers in Iran, 1990–2015, Asia-Pacific Journal of Clinical Oncology (2019)
33. Trends in the Drowning Mortality Rate in Iran, Injury Prevention (2020)